Velan Capital Investment Management Lp Top Holdings and 13F Report (2026)

About Velan Capital Investment Management Lp

Investment Activity

Velan Capital Investment Management Lp has $159.65 million in total holdings as of March 31, 2026.
Velan Capital Investment Management Lp owns shares of 49 different stocks, but just 13 companies or ETFs make up 80% of its holdings.
Approximately 23.36% of the portfolio was purchased this quarter.
About 31.33% of the portfolio was sold this quarter.
This quarter, Velan Capital Investment Management Lp has purchased 46 new stocks and bought additional shares in 12 stocks.
Velan Capital Investment Management Lp sold shares of 7 stocks and completely divested from 9 stocks this quarter.

Largest Holdings

PRAXIS PRECISION MEDICINES I: $32,470,630
Protara Therapeutics: $14,768,537
SUTRO BIOPHARMA INC: $12,757,906
EVOMMUNE INC: $10,259,402
MAPLIGHT THERAPEUTICS INC: $10,020,515

Largest New Holdings this Quarter

03675P102 - ANTERIS TECHNOLOGIES GLOBAL: $3,885,000 Holding
98401F105 - Xencor: $3,015,000 Holding
55083R203 - LYELL IMMUNOPHARMA INC: $2,046,120 Holding
77313F106 - Rocket Pharmaceuticals: $1,054,822 Holding
M7071P109 - NASUS PHARMA LTD: $797,846 Holding

Largest Purchases this Quarter

TENAX THERAPEUTICS INC: 500,000 shares (about $8.00M)
Immix Biopharma: 705,000 shares (about $6.42M)
SUTRO BIOPHARMA INC: 200,160 shares (about $4.99M)
ANTERIS TECHNOLOGIES GLOBAL: 700,000 shares (about $3.89M)
Xencor: 250,000 shares (about $3.02M)

Largest Sales this Quarter

Mineralys Therapeutics: 140,000 shares (about $3.79M)
Syndax Pharmaceuticals: 120,000 shares (about $2.80M)
EVOMMUNE INC: 60,499 shares (about $1.39M)
KAZIA THERAPEUTICS LTD: 164,685 shares (about $1.23M)
AVALO THERAPEUTICS INC: 78,520 shares (about $1.17M)

Sector Allocation Over Time

Selling

Neutral

Buying

Latest 13F Holdings and Changes Since Previous Quarterly Filing

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
PRAXIS PRECISION MEDICINES I	$32,470,630		0.0%	100,781	20.3%	COM NEW
TARA Protara Therapeutics	$14,768,537		0.0%	2,834,652	9.3%	Medical
SUTRO BIOPHARMA INC	$12,757,906	$4,985,986 â–²	64.2%	512,160	8.0%	COM SHS
EVOMMUNE INC	$10,259,402	$1,390,872 â–¼	-11.9%	446,255	6.4%	COM SHS
MAPLIGHT THERAPEUTICS INC	$10,020,515	$597,946 â–¼	-5.6%	492,893	6.3%	COM
TENAX THERAPEUTICS INC	$9,327,495	$7,995,000 â–²	600.0%	583,333	5.8%	COM NEW
ABIVAX SA	$8,573,950	$1,113,500 â–²	14.9%	77,000	5.4%	SPONSORED ADS
HRTX Heron Therapeutics	$7,003,507		0.0%	8,753,290	4.4%	Medical
IMMX Immix Biopharma	$6,741,400	$6,422,550 â–²	2,014.3%	740,000	4.2%	Medical
ESPR Esperion Therapeutics	$4,712,800	$1,397,400 â–²	42.1%	1,720,000	3.0%	Medical
EDESA BIOTECH INC	$4,327,825	$732,200 â–²	20.4%	827,500	2.7%	COM NEW
ANTERIS TECHNOLOGIES GLOBAL	$3,885,000	$3,885,000 â–²	New Holding	700,000	2.4%	COM
NSPR InspireMD	$3,422,433	$71,795 â–¼	-2.1%	2,099,652	2.1%	Medical
XNCR Xencor	$3,015,000	$3,015,000 â–²	New Holding	250,000	1.9%	Medical
AVALO THERAPEUTICS INC	$2,763,871	$1,172,303 â–¼	-29.8%	185,122	1.7%	COM NEW
EUPRAXIA PHARMACEUTICALS INC	$2,548,480		0.0%	352,000	1.6%	COM
CTMX CytomX Therapeutics	$2,538,000	$2,162,000 â–²	575.0%	540,000	1.6%	Medical
VERRICA PHARMACEUTICALS INC	$2,494,547		0.0%	471,559	1.6%	COM SHS
JASPER THERAPEUTICS INC	$2,338,047		0.0%	2,668,395	1.5%	COM NEW
RZLT Rezolute	$2,287,500		0.0%	750,000	1.4%	Medical
LYELL IMMUNOPHARMA INC	$2,046,120	$2,046,120 â–²	New Holding	102,000	1.3%	COM NEW
PROF Profound Medical	$1,851,401		0.0%	285,710	1.2%	Medical
VRDN Viridian Therapeutics	$1,782,366	$90,426 â–²	5.3%	91,123	1.1%	Medical
RCKT Rocket Pharmaceuticals	$1,054,822	$1,054,822 â–²	New Holding	294,643	0.7%	Medical
KAZIA THERAPEUTICS LTD	$1,006,744	$1,225,257 â–¼	-54.9%	135,315	0.6%	SPONSORED ADS
NASUS PHARMA LTD	$797,846	$797,846 â–²	New Holding	359,390	0.5%	ORD SHS
QUOIN PHARMACEUTICALS LTD	$560,003	$560,003 â–²	New Holding	84,849	0.4%	SPONSORED ADS
ARWR Arrowhead Pharmaceuticals	$407,550		0.0%	6,500	0.3%	Medical
PTGX Protagonist Therapeutics	$389,980		0.0%	3,700	0.2%	Medical
OVID Ovid Therapeutics	$355,200		0.0%	160,000	0.2%	Medical
MLYS Mineralys Therapeutics	$297,990	$3,792,600 â–¼	-92.7%	11,000	0.2%	Medical
CNTX Context Therapeutics	$262,000		0.0%	100,000	0.2%	Medical
NRIX Nurix Therapeutics	$248,000		0.0%	16,000	0.2%	Medical
CRBP Corbus Pharmaceuticals	$244,140	$122,070 â–²	100.0%	26,000	0.2%	Medical
SNDX Syndax Pharmaceuticals	$233,600	$2,803,200 â–¼	-92.3%	10,000	0.1%	Medical
PRECISION BIOSCIENCES INC	$220,000	$110,000 â–²	100.0%	40,000	0.1%	COM NEW
IMNM Immunome	$218,700		0.0%	10,000	0.1%	Medical
DSGN Design Therapeutics	$212,800		0.0%	20,000	0.1%	Medical
ARTIVA BIOTHERAPEUTICS INC	$161,000	$161,000 â–²	New Holding	25,000	0.1%	COM
NEUMORA THERAPEUTICS INC.	$156,000	$156,000 â–²	New Holding	80,000	0.1%	COM
REPL Replimune Group	$153,000	$38,250 â–²	33.3%	20,000	0.1%	Medical
LRMR Larimar Therapeutics	$148,500		0.0%	33,000	0.1%	Medical
XILIO THERAPEUTICS INC	$120,137	$120,137 â–²	New Holding	14,285	0.1%	COM
KALARIS THERAPEUTICS INC	$103,860	$103,860 â–²	New Holding	18,000	0.1%	COM
PMVP PMV Pharmaceuticals	$90,520	$47,120 â–²	108.6%	73,000	0.1%	Medical
MGNX MacroGenics	$86,700	$86,700 â–²	New Holding	30,000	0.1%	Medical
KARYOPHARM THERAPEUTICS INC	$83,550	$83,550 â–²	New Holding	15,000	0.1%	COM NEW
PRQR ProQR Therapeutics	$72,900		0.0%	45,000	0.0%	Medical
GOSS Gossamer Bio	$22,995		0.0%	70,000	0.0%	Medical
CIDARA THERAPEUTICS INC	$0	$23,945,360 â–¼	-100.0%	0	0.0%	COM NEW
LNTH Lantheus	$0	$4,970,420 â–¼	-100.0%	0	0.0%	Medical
RAPT THERAPEUTICS INC	$0	$3,657,960 â–¼	-100.0%	0	0.0%	COM NEW
TERN Terns Pharmaceuticals	$0	$2,828,000 â–¼	-100.0%	0	0.0%	Medical
TRVI Trevi Therapeutics	$0	$2,566,600 â–¼	-100.0%	0	0.0%	Medical
TREVI THERAPEUTICS INC	$0	$482,020 â–¼	-100.0%	0	0.0%	CALL
VTYX Ventyx Biosciences	$0	$361,200 â–¼	-100.0%	0	0.0%	Medical
XLO Xilio Therapeutics	$0	$108,834 â–¼	-100.0%	0	0.0%	Medical
PYXS Pyxis Oncology	$0	$46,000 â–¼	-100.0%	0	0.0%	Medical

Showing largest 100 holdings. View all holdings.

More Institutional Buying and Selling Information

SEC Filings and Trading Data

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Velan Capital Investment Management Lp Top Holdings and 13F Report (2026)

About Velan Capital Investment Management Lp

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Velan Capital Investment Management Lp Top Holdings and 13F Report (2026)

About Velan Capital Investment Management Lp

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Map of 500 Largest Holdings ofVelan Capital Investment Management Lp

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools